Chartwell Investment Partners’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Chartwell Investment Partners’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-83,325	Closed	-$3.03M	–	458
2016 Q4	$3.03M	Sell	83,325 -143,715	-63%	-$5.08M	0.1%	273
2016 Q3	$8.66M	Buy	+227,040	New	+$3.36M	0.15%	193

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Chartwell Investment Partners's CLCD Position: Q1 2017 in Review

Chartwell Investment Partners sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 83,325 shares — an estimated $3.03M sold.

Chartwell Investment Partners first reported a position in CLCD in Q3 2016 and held it in 2 quarters. The position peaked at $8.66M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Chartwell Investment Partners reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Chartwell Investment Partners sold 83,325 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $3.03M.
Chartwell Investment Partners first reported a position in CoLucid Pharmaceuticals, Inc. in Q3 2016 and held it in 2 quarters.
Chartwell Investment Partners's CoLucid Pharmaceuticals, Inc. position peaked at $8.66M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Chartwell Investment Partners's 13F filing for Q1 2017, filed 12 May 2017.